Federal Register / Vol. 62, No. 56 / Monday, March 24, 1997 / Notices 13887

successor in interest to the Federal

Savings and Loan Insurance Corporation

as receiver for Butterfield Savings and

Loan Association, Santa Ana, California,

has determined that the proceeds which

can be realized from the liquidation of

the assets of the receivership estate are

insufficient to allow a dividend,

distribution or payment to any holder of

a claim or equity interest. Therefore, any

such claims or interests are hereby

determined to be worthless.

FOR FURTHER INFORMATION CONTACT:

Thomas Bolt, Counsel, Legal Division,

FDIC, 550 17th Street, NW., Room H–

11048, Washington, DC 20429.

Telephone: (202) 736–0168.

Dated: March 18, 1997.

Robert E. Feldman,

Deputy Executive Secretary.

[FR Doc. 97–7326 Filed 3–21–97; 8:45 am]

BILLING CODE 6714–01–P

Sunshine Act Meeting; Notice of a

Matter To Be Withdrawn From the

Agenda for Consideration at an

Agency Meeting

Pursuant to the provisions of the

‘‘Government in the Sunshine Act’’ (5

U.S.C. 552b), notice is hereby given that

the following matter will be withdrawn

from the ‘‘discussion agenda’’ for

consideration at the open meeting of the

Board of Directors of the Federal

Deposit Insurance Corporation

scheduled to be held at 10:00 a.m. on

Tuesday, March 25, 1997, in the Board

Room on the sixth floor of the FDIC

Building located at 550 17th Street,

N.W., Washington, D.C.:

Memorandum and resolution re:

Proposed Rule Regarding Deposit

Insurance Simplification.

Requests for further information

concerning the meeting may be directed

to Mr. Robert E. Feldman, Deputy

Executive Secretary of the Corporation,

at (202) 898–6757.

Dated: March 20, 1997.

Federal Deposit Insurance Corporation

Robert E. Feldman,

Deputy Executive Secretary.

[FR Doc. 97–7481 Filed 3–20–97; 2:13 pm]

BILLING CODE 6714–01–M

FEDERAL RESERVE SYSTEM

Change in Bank Control Notices;

Acquisitions of Shares of Banks or

Bank Holding Companies

The notificants listed below have

applied under the Change in Bank

Control Act (12 U.S.C. 1817(j)) and §

225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire a bank or bank

holding company. The factors that are

considered in acting on the notices are

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

notices have been accepted for

processing, they will also be available

for inspection at the offices of the Board

of Governors. Interested persons may

express their views in writing to the

Reserve Bank indicated for that notice

or to the offices of the Board of

Governors. Comments must be received

not later than April 7, 1997.

A. Federal Reserve Bank of

Minneapolis (Karen L. Grandstrand,

Vice President) 250 Marquette Avenue,

Minneapolis, Minnesota 55480-2171:

1. Theodore J. Hofer, Freeman, South

Dakota; to acquire an additional 3.4

percent, for a total of 35.8 percent, of the

voting shares of H & W Holding

Company, Freeman, South Dakota, and

thereby indirectly acquire Merchants

State Bank, Freeman, South Dakota.

B. Federal Reserve Bank of Kansas

City (John E. Yorke, Senior Vice

President) 925 Grand Avenue, Kansas

City, Missouri 64198-0001:

1. Morris Mayer Testamentary Trust,

Dale Walkenhorst as Trustee, Madison,

Nebraska; to acquire 26.91 percent of

the voting shares of Madison

Bancshares, Inc., Madison, Nebraska,

and thereby indirectly acquire Bank of

Madison, Madison, Nebraska.

C. Federal Reserve Bank of Dallas

(Genie D. Short, Vice President) 2200

North Pearl Street, Dallas, Texas 75201-

2272:

1. Donald Edward Powell, Amarillo,

Texas; to acquire 100 percent of the

voting shares of Tejas Bancshares, Inc.,

Fritch, Texas, and thereby indirectly

acquire Fritch State Bank, Fritch, Texas.

Board of Governors of the Federal Reserve

System, March 18, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–7298 Filed 3-21-97; 8:45 am]

BILLING CODE 6210-01-F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Notice of Four Meetings of the National

Bioethics Advisory Commission

(NBAC)

SUMMARY: Pursuant to Section 10(d) of

the Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is given of four meetings of the National

Bioethics Advisory Commission. The

Commission will continue discussing its

response to the President’s request to

review the legal and ethical

implications of the possible cloning of

humans following the discovery of a

technique for cloning sheep. The

Commission is to report to the President

in late May. This scientific finding

raises a host of issues including ethical

questions, in particular, the possible use

of this technique to clone human

embryos, as well as the promise of

benefits in a number of areas. The

meetings are open to the public and

opportunities for statements by the

public will be provided.

Dates/Times/Locations

Sunday, April 13, 1997, 7:30 a.m.–3:30

p.m.—Crystal City Marriott, 1999

Jefferson Davis Highway, Arlington,

VA. 22202

Friday, May 2, 1997, 7:30 a.m.–3:30

p.m.—Sheraton Crystal City, 1800

Jefferson Davis Highway, Arlington,

VA. 22202

Saturday, May 17, 1997, 7:30 a.m.–3:30

p.m.—Crystal City Marriott, 1999

Jefferson Davis Highway, Arlington,

VA. 22202

Saturday, June 7, 1997, 7:30 a.m.–3:30

p.m.—Crystal City Marriott, 1999

Jefferson Davis Highway, Arlington,

VA. 22202

SUPPLEMENTARY INFORMATION: The

President established the National

Bioethics Advisory Commission (NBAC)

by Executive Order 12975 on October 3,

1995. The general mission of the NBAC

is to advise and make recommendations

to the National Science and Technology

Council and other entities on bioethical

issues arising from the research on

human biology and behavior, and in the

applications of that research including

clinical applications. On the issue of

cloning, the Commission is to undertake

a thorough review of the legal and

ethical issues associated with the use of

this technology, and report back to the

President with recommendations on

possible federal actions to prevent its

abuse.

Tentative Agenda

The Commission will continue its

review of the legal and ethical issues

associated with the possible cloning of

human beings and may hear from a

number of invited speakers who are

experts in their fields. Because of the

very short lead time, more details are

not yet available. Agendas will be

available shortly before each meeting

(see details below).

Public Participation

The meetings are open to the public

with attendance limited by the